NanoBio Announces Closing of $22 Million Series B Financing Round
ANN ARBOR - NanoBio Corp., a biopharmaceutical company, announced Wednesday that it has closed a $22 million Series B financing round after recently securing an additional $10 million investment from NanoBio's majority shareholder Perseus, L.L.C., based in New York, N.Y., and Venture Investors of Madison, Wis. and Ann Arbor. The $10 million is in addition